Quantcast

Latest Vaccination Stories

2014-09-10 23:01:22

"Vaccines save lives. We now can protect our youth from diseases including cancer — who doesn't want that protection for his or her child?” declares Amy Middleman, MD, MPH, MSEd, FSAHM, adolescent health expert featured in PBS special. Deerfield, IL (PRWEB) September 10, 2014 Vaccines aren’t just for infants; teens and young adults benefit greatly from a number of vaccines that prevent various cancers and other illnesses. This is the message of a new film from PBS/NOVA,...

2014-09-10 08:32:30

ANNAPOLIS, Md., Sept. 10, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a contract, valued at up to $28.1 million if all contract options are exercised, for the development of a next generation anthrax vaccine based on the...

2014-09-09 16:27:02

SANTA MONICA, Calif., Sept. 9, 2014 /PRNewswire-USNewswire/ -- America's leading provider of free pro and con research on controversial issues, ProCon.org (online at www.procon.org), has published new information and resources in the debate over whether vaccines should be mandatory for children. The pro and con vaccines information is available online at the free nonpartisan website vaccines.procon.org. http://photos.prnewswire.com/prnvar/20130208/MM57290LOGO In response to the core...

2014-09-09 08:33:14

ANNAPOLIS, Md., Sept. 9, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP) announced today that recent non-clinical animal data from its SparVax(®) anthrax vaccine program were presented at the 54(th) Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC. In a poster presentation entitled, "Enhanced Next Generation rPA Vaccine Induces Immunogenicity and Efficacy at Least Equivalent to AVA in the New Zealand White (NZW) Rabbit Model for Anthrax," Dr....

2014-09-09 08:32:26

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Human Vaccine Technologies Market" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Immunization is one of the highest impact and most cost effective methods of preventing infectious diseases, particularly in low and middle income countries with minimal healthcare facilities in remote locations. Many vaccines technologies that could aid improved safety, efficacy and...

2014-09-09 08:30:50

New patent includes composition of matter claims PRINCETON, N.J., Sept. 9, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the US Patent and Trademark Office (US PTO) granted patent 8,808,710 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine...

2014-09-08 16:25:31

The Encore at Wynn Las Vegas: September 11th, 2014 ZUG, Switzerland and NEW YORK, Sept. 8, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various indications in cancer and the central nervous system (CNS), including orphan indications, today announced that Dr. Angelos M. Stergiou, Chief Executive Officer and Chairman of the Board of SELLAS, will...

2014-09-08 16:25:02

Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination SWIFTWATER, Pa., Sept. 8, 2014 /PRNewswire-USNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) approved use of Menactra(®) [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal...

2014-09-08 08:29:28

Presentation to be Webcast Live, 1:15 PM EDT, September 9th PRINCETON, N.J., Sept. 8, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will give a corporate presentation at the 16(th) Annual Rodman & Renshaw Global...

2014-09-06 23:01:05

Global Animal Vaccines Market 2014-2018 and Global Animal Health Market 2014-2018 are new research reports added to Sandlerresearch.org store. Dallas, Texas (PRWEB) September 06, 2014 One of the major emerging trends in this market is an increase in acquisitions. Vendors have been focusing on acquisitions to increase their foothold in the market through increased investments. According to the “Global Animal Vaccines Market 2014-2018” report, one of the main drivers of this market is...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related